Treatment with Retevmo improved progression-free survival and overall response rate in patients with advanced RET-mutant medullary thyroid cancer who were ...

The treatment combination of Rybrevant plus chemotherapy offers better progression-free survival for patients with advanced EGFR exon 20 insertion-positive ...

Patients with ALK-positive, early-stage non-small cell lung cancer obtained significant improvement in disease-free survival.Patients with resected ...

Perioperative Opdivo improved outcomes for certain patients with non-small cell lung cancer.Neoadjuvant (pre-surgical) treatment with Opdivo (nivolumab) ...

The Food and Drug Administration (FDA) approved an expanded indication for Rozlytrek (entrectinib) to include children older than one month with solid ...

Verzenio plus endocrine therapy improved outcomes for patients with HR-positive, HER2-negative breast cancer, according to research.Two years of Verzenio ...

Adding Keytruda (pembrolizumab) to external beam radiotherapy (EBRT) and simultaneous chemotherapy, followed by brachytherapy, lengthened the time to ...

Patients with newly diagnosed advanced ovarian cancer — regardless of their BRCA mutation status — tended to experience a reduction in the risk of ...

Tarlatamab was safe and effective in treating patients with small cell lung cancer, study results showed. Tarlatamab, a form of immunotherapy called a ...

In the last few years, I have gone from being a cancer patient to advocating for others in the cancer space. I’m learning that sometimes being in the room ...